Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

MLL1 is essential for retinal neurogenesis and horizontal inner neuron integrity.

Brightman DS, Grant RL, Ruzycki PA, Suzuki R, Hennig AK, Chen S.

Sci Rep. 2018 Aug 9;8(1):11902. doi: 10.1038/s41598-018-30355-3.

2.

Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.

Greig JA, Calcedo R, Grant RL, Peng H, Medina-Jaszek CA, Ahonkhai O, Qin Q, Roy S, Tretiakova AP, Wilson JM.

Vaccine. 2016 Dec 7;34(50):6323-6329. doi: 10.1016/j.vaccine.2016.10.053. Epub 2016 Nov 3.

PMID:
27817961
3.

Exercise facilities for neurologically disabled populations - Perceptions from the fitness industry.

Anderson C, Grant RL, Hurley MV.

Disabil Health J. 2017 Jan;10(1):157-162. doi: 10.1016/j.dhjo.2016.09.006. Epub 2016 Sep 16.

PMID:
27687636
4.

Differential timing of granule cell production during cerebellum development underlies generation of the foliation pattern.

Legué E, Gottshall JL, Jaumouillé E, Roselló-Díez A, Shi W, Barraza LH, Washington S, Grant RL, Joyner AL.

Neural Dev. 2016 Sep 8;11(1):17. doi: 10.1186/s13064-016-0072-z.

5.

Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study.

Beck NB, Becker RA, Erraguntla N, Farland WH, Grant RL, Gray G, Kirman C, LaKind JS, Jeffrey Lewis R, Nance P, Pottenger LH, Santos SL, Shirley S, Simon T, Dourson ML.

Environ Int. 2016 Apr-May;89-90:110-28. doi: 10.1016/j.envint.2015.12.031. Epub 2016 Jan 28.

6.

Assessment of chronic inhalation non-cancer toxicity for diethylamine.

Grant RL, Taiwo SO, McCant D.

Inhal Toxicol. 2015;27(14):778-86. doi: 10.3109/08958378.2015.1103338.

7.

Use of In Vivo and In Vitro Data to Derive a Chronic Reference Value for Crotonaldehyde Based on Relative Potency to Acrolein.

Grant RL, Jenkins AF.

J Toxicol Environ Health B Crit Rev. 2015;18(7-8):327-43. doi: 10.1080/10937404.2015.1081574. Epub 2015 Nov 18. Review.

8.

The Sling Shot Appliance.

Grant RL.

Int J Orthod Milwaukee. 2015 Summer;26(2):77-9. No abstract available.

PMID:
26349295
9.

Development of a chronic inhalation reference value for hexamethylenediamine using an exposure model based on the dihydrochloride salt.

Myers JL, Grant RL.

Inhal Toxicol. 2015;27(9):440-9. doi: 10.3109/08958378.2015.1068891. Epub 2015 Jul 27.

PMID:
26213288
10.

Physician associates and GPs in primary care: a comparison.

Drennan VM, Halter M, Joly L, Gage H, Grant RL, Gabe J, Brearley S, Carneiro W, de Lusignan S.

Br J Gen Pract. 2015 May;65(634):e344-50. doi: 10.3399/bjgp15X684877.

11.

Evaluation of the effectiveness of a home-based inspiratory muscle training programme in patients with chronic obstructive pulmonary disease using multiple inspiratory muscle tests.

Nikoletou D, Man WD, Mustfa N, Moore J, Rafferty G, Grant RL, Johnson L, Moxham J.

Disabil Rehabil. 2016;38(3):250-9. doi: 10.3109/09638288.2015.1036171. Epub 2015 Apr 17.

12.

Health- and vegetative-based effect screening values for ethylene.

Erraguntla NK, Grant RL.

Chem Biol Interact. 2015 Nov 5;241:87-93. doi: 10.1016/j.cbi.2015.02.010. Epub 2015 Feb 26.

PMID:
25727267
13.

Emissions and ambient air monitoring trends of lower olefins across Texas from 2002 to 2012.

Myers JL, Phillips T, Grant RL.

Chem Biol Interact. 2015 Nov 5;241:2-9. doi: 10.1016/j.cbi.2015.02.008. Epub 2015 Feb 26.

PMID:
25727265
14.

Intramuscular injection of AAV8 in mice and macaques is associated with substantial hepatic targeting and transgene expression.

Greig JA, Peng H, Ohlstein J, Medina-Jaszek CA, Ahonkhai O, Mentzinger A, Grant RL, Roy S, Chen SJ, Bell P, Tretiakova AP, Wilson JM.

PLoS One. 2014 Nov 13;9(11):e112268. doi: 10.1371/journal.pone.0112268. eCollection 2014.

15.

Sniff nasal inspiratory pressure in patients with moderate-to-severe chronic obstructive pulmonary disease: learning effect and short-term between-session repeatability.

Nikoletou D, Rafferty G, Man WD, Mustfa N, Donaldson N, Grant RL, Johnson L, Moxham J.

Respiration. 2014;88(5):365-70. doi: 10.1159/000365998. Epub 2014 Aug 30.

16.

Relative stopping power measurements to aid in the design of anthropomorphic phantoms for proton radiotherapy.

Grant RL, Summers PA, Neihart JL, Blatnica AP, Sahoo N, Gillin MT, Followill DS, Ibbott GS.

J Appl Clin Med Phys. 2014 Mar 6;15(2):4523. doi: 10.1120/jacmp.v15i2.4523.

17.

Clinical decision making and preference assessment for individuals with intellectual and developmental disabilities.

Virués-Ortega J, Pritchard K, Grant RL, North S, Hurtado-Parrado C, Lee MS, Temple B, Julio F, Yu CT.

Am J Intellect Dev Disabil. 2014 Mar;119(2):151-70. doi: 10.1352/1944-7558-119.2.151. Review.

PMID:
24679351
18.

Trends over time in prescribing by English primary care nurses: a secondary analysis of a national prescription database.

Drennan VM, Grant RL, Harris R.

BMC Health Serv Res. 2014 Feb 6;14:54. doi: 10.1186/1472-6963-14-54.

19.

Converting an odds ratio to a range of plausible relative risks for better communication of research findings.

Grant RL.

BMJ. 2014 Jan 24;348:f7450. doi: 10.1136/bmj.f7450. Review. No abstract available. Erratum in: BMJ. 2014;348:g2124.

PMID:
24464277
20.

Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study.

Iqbal K, Gifford KA, Ibbott G, Grant RL, Buzdar S.

J Appl Clin Med Phys. 2014 Jan 6;15(1):4531. doi: 10.1120/jacmp.v15i1.4531.

21.

Independent dose per monitor unit review of eight U.S.A. proton treatment facilities.

Moyers MF, Ibbott GS, Grant RL, Summers PA, Followill DS.

Med Phys. 2014 Jan;41(1):012103. doi: 10.1118/1.4845135.

22.

First diagnosis and management of incontinence in older people with and without dementia in primary care: a cohort study using The Health Improvement Network primary care database.

Grant RL, Drennan VM, Rait G, Petersen I, Iliffe S.

PLoS Med. 2013 Aug;10(8):e1001505. doi: 10.1371/journal.pmed.1001505. Epub 2013 Aug 27.

23.

Impact of three interactive Texas state regulatory programs to decrease ambient air toxic levels.

Capobianco T, Hildebrand SM, Honeycutt M, Lee JS, McCant D, Grant RL.

J Air Waste Manag Assoc. 2013 May;63(5):507-20.

PMID:
23786142
24.

The Chelsea critical care physical assessment tool (CPAx): validation of an innovative new tool to measure physical morbidity in the general adult critical care population; an observational proof-of-concept pilot study.

Corner EJ, Wood H, Englebretsen C, Thomas A, Grant RL, Nikoletou D, Soni N.

Physiotherapy. 2013 Mar;99(1):33-41. doi: 10.1016/j.physio.2012.01.003. Epub 2012 Mar 30.

PMID:
23219649
25.

Predictors of two forms of attrition in a longitudinal health study involving ageing participants: an analysis based on the Whitehall II study.

Mein G, Johal S, Grant RL, Seale C, Ashcroft R, Tinker A.

BMC Med Res Methodol. 2012 Oct 29;12:164. doi: 10.1186/1471-2288-12-164.

26.

Description of a successful collaborative birth center practice among midwives and an obstetrician.

Stevens JR, Witmer TL, Grant RL, Cammarano DJ 3rd.

Obstet Gynecol Clin North Am. 2012 Sep;39(3):347-57. doi: 10.1016/j.ogc.2012.05.003. Epub 2012 Aug 11.

PMID:
22963694
27.

Graduates from dual qualification courses, registered nurse and health visitor: a career history study.

Drennan VM, Porter EM, Grant RL.

Nurse Educ Today. 2013 Aug;33(8):925-30. doi: 10.1016/j.nedt.2012.08.001. Epub 2012 Aug 31.

PMID:
22939771
28.

An updated inhalation unit risk factor for arsenic and inorganic arsenic compounds based on a combined analysis of epidemiology studies.

Erraguntla NK, Sielken RL Jr, Valdez-Flores C, Grant RL.

Regul Toxicol Pharmacol. 2012 Nov;64(2):329-41. doi: 10.1016/j.yrtph.2012.07.001. Epub 2012 Jul 17.

PMID:
22813725
30.

Quantitative human health risk assessment for 1,3-butadiene based upon ovarian effects in rodents.

Kirman CR, Grant RL.

Regul Toxicol Pharmacol. 2012 Mar;62(2):371-84. doi: 10.1016/j.yrtph.2011.11.001. Epub 2011 Nov 10.

PMID:
22100993
31.

Development of a unit risk factor for nickel and inorganic nickel compounds based on an updated carcinogenic toxicity assessment.

Haney JT Jr, McCant DD, Sielken RL Jr, Valdez-Flores C, Grant RL.

Regul Toxicol Pharmacol. 2012 Feb;62(1):191-201. doi: 10.1016/j.yrtph.2011.10.005. Epub 2011 Oct 14.

PMID:
22019551
32.

Glucose meters and opportunities for in-hospital transmission of infection: Quantitative assessment and management with and without patient assignment.

Hellinger WC, Grant RL, Hernke DA, Shalev JA, Barber BW, Meek SE, Jones AD, Thompson KM.

Am J Infect Control. 2011 Nov;39(9):752-6. doi: 10.1016/j.ajic.2010.12.019. Epub 2011 Jun 23.

PMID:
21700364
33.

Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors.

Wang L, Calcedo R, Bell P, Lin J, Grant RL, Siegel DL, Wilson JM.

Hum Gene Ther. 2011 Nov;22(11):1389-401. doi: 10.1089/hum.2011.031. Epub 2011 Jun 8.

34.

Three-Dimensional Dosimetry of a Beta-Emitting Radionuclide Using PRESAGE Dosimeters.

Grant RL, Crowder ML, Ibbott GS, Simon J, Frank RK, Rogers J, Loy HM, Adamovics J, Newton J, Oldham M, Stearns S, Wendt RE.

J Phys Conf Ser. 2010 Dec 7;250(1). pii: 012095.

35.

Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors.

Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG.

Pharmacoeconomics. 2011 Mar;29(3):225-37. doi: 10.2165/11584200-000000000-00000.

PMID:
21062104
36.

A chronic reference value for 1,3-butadiene based on an updated noncancer toxicity assessment.

Grant RL, Haney J, Curry AL, Honeycutt M.

J Toxicol Environ Health B Crit Rev. 2010 Aug;13(6):460-75. doi: 10.1080/10937404.2010.499735. Review.

PMID:
20711928
37.

Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness.

Amado D, Mingozzi F, Hui D, Bennicelli JL, Wei Z, Chen Y, Bote E, Grant RL, Golden JA, Narfstrom K, Syed NA, Orlin SE, High KA, Maguire AM, Bennett J.

Sci Transl Med. 2010 Mar 3;2(21):21ra16. doi: 10.1126/scitranslmed.3000659.

38.

Development of a unit risk factor for 1,3-butadiene based on an updated carcinogenic toxicity assessment.

Grant RL, Haney J, Curry AL, Honeycutt M.

Risk Anal. 2009 Dec;29(12):1726-42. doi: 10.1111/j.1539-6924.2009.01302.x. Epub 2009 Oct 29.

PMID:
19878488
39.

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.

Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG; National Institute for Health and Clinical Excellence Osteoarthritis Guideline Development Group.

BMJ. 2009 Jul 14;339:b2538. doi: 10.1136/bmj.b2538.

40.

Staffing levels and patient dependence in English stroke units.

Rudd AG, Jenkinson D, Grant RL, Hoffman A.

Clin Med (Lond). 2009 Apr;9(2):110-5.

PMID:
19435112
41.

Care and management of osteoarthritis in adults: summary of NICE guidance.

Conaghan PG, Dickson J, Grant RL; Guideline Development Group.

BMJ. 2008 Mar 1;336(7642):502-3. doi: 10.1136/bmj.39490.608009.AD. No abstract available.

42.

Evaluation of acute inhalation toxicity for chemicals with limited toxicity information.

Grant RL, Kadlubar BJ, Erraguntla NK, Honeycutt M.

Regul Toxicol Pharmacol. 2007 Apr;47(3):261-73. Epub 2007 Jan 31.

PMID:
17275156
43.

OMT and FJO: an integrated treatment for TMD.

Grant RL.

Int J Orthod Milwaukee. 2006 Winter;17(4):31-5. No abstract available.

PMID:
17256441
44.

Spatial and temporal trend evaluation of ambient concentrations of 1,3-butadiene and chloroprene in Texas.

Grant RL, Leopold V, McCant D, Honeycutt M.

Chem Biol Interact. 2007 Mar 20;166(1-3):44-51. Epub 2006 Aug 22.

PMID:
17011534
45.

Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.

Vandenberghe LH, Wang L, Somanathan S, Zhi Y, Figueredo J, Calcedo R, Sanmiguel J, Desai RA, Chen CS, Johnston J, Grant RL, Gao G, Wilson JM.

Nat Med. 2006 Aug;12(8):967-71. Epub 2006 Jul 16.

PMID:
16845388
46.

Corrigendum to "Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman Primates".

Gao G, Lu Y, Calcedo R, Grant RL, Bell P, Wang L, Figueredo J, Lock M, Wilson JM.

Mol Ther. 2006 Jul;14(1):150. doi: 10.1016/j.ymthe.2006.04.002. Epub 2006 May 30. No abstract available.

47.

Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates.

Gao G, Lu Y, Calcedo R, Grant RL, Bell P, Wang L, Figueredo J, Lock M, Wilson JM.

Mol Ther. 2006 Jan;13(1):77-87. Epub 2005 Oct 10. Erratum in: Mol Ther. 2006 Jul;14(1):150.

48.

Ultrasound detection of a subperiosteal abscess secondary to coalescent otomastoiditis.

Grant RL, Piotto L.

Australas Radiol. 2005 Aug;49(4):312-4.

PMID:
16026438
49.

Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates.

Lebherz C, Auricchio A, Maguire AM, Rivera VM, Tang W, Grant RL, Clackson T, Bennett J, Wilson JM.

Hum Gene Ther. 2005 Feb;16(2):178-86.

PMID:
15761258
50.

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

Rivera VM, Gao GP, Grant RL, Schnell MA, Zoltick PW, Rozamus LW, Clackson T, Wilson JM.

Blood. 2005 Feb 15;105(4):1424-30. Epub 2004 Oct 26.

Supplemental Content

Loading ...
Support Center